Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-26 @ 2:14 AM
Study NCT ID:
NCT03700905
Status:
UNKNOWN
Last Update Posted:
2023-05-23
First Post:
2018-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization: